Candesartan cilexetil in cardiovascular prevention
Effectiveness and good tolerability of angiotensin receptor antagonists (ARA) in arterial hypertension (AH) have been demonstrated in large-scale randomized clinical trials. Substantial pharmacodynamic differences between various ARA, potentially playing important clinical roles, were identified. Ca...
Saved in:
Main Author: | A. Ya. Ivleva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2007-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1433 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization and validation of UPLC method for dapagliflozin and candesartan cilexetil in an on-demand formulation: Analytical quality by design approach
by: Elzayat Ehab M., et al.
Published: (2025-07-01) -
Technological approaches to improve the bioavailability of the poor soluble substance Candesartan Cilexetil in mini-tablets
by: K. M. Tserkovnaya, et al.
Published: (2025-03-01) -
Candesartan effectiveness in essential arterial hypertension and renal arterial hypertension
by: N. M. Chikhladze, et al.
Published: (2008-12-01) -
Simultaneous Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC-MS/MS
by: P. K. Karnakova, et al.
Published: (2021-11-01) -
BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
by: M. V. Leonova
Published: (2015-12-01)